Literature DB >> 15651542

Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease.

Giovanna Pasculli1, Francesco Resta, Edoardo Guastamacchia, Leonardo Di Gennaro, Patrizia Suppressa, Carlo Sabbà.   

Abstract

The levels of the health-related quality of life (HR-QoL) were analyzed in hereditary hemorrhagic telangiectasia (HHT) patients. The Short Form-36 Health Survey (SF-36) was administered to 50 HHT patients and scores were compared to a cohort of 2301 normal subjects. Clinical variables were patient age, illness duration, number of epistaxis episodes in the previous year and hemoglobin levels. Physical functioning, physical role limitations, bodily pain, social functioning, emotional role limitations and the physical component scores were lower among females. In multivariable analyses increasing age was related to lower physical functioning (p < 0.04), physical role limitations (p < 0.008), bodily pain (p < 0.05) and emotional role limitations (p < 0.01), while higher hemoglobin levels improved physical functioning (p < 0.03). The number of epistaxis episodes was negatively associated with physical role limitations (p < 0.009), vitality (p < 0.002), social functioning (p < 0.001), physical component summary (p < 0.001) and bodily pain (p < 0.01). Illness duration was negatively related to the mental component summary (p < 0.004). HHT patients had a lower HR-QoL with respect to normal controls in all domains except for bodily pain. Females had lower scores for several domains. Epistaxis was the most important clinical variable.

Entities:  

Mesh:

Year:  2004        PMID: 15651542     DOI: 10.1007/s11136-004-7865-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

1.  Effect of higher hemoglobin levels on health-related quality of life parameters.

Authors:  Nancy Gregory
Journal:  Nephrol Nurs J       Date:  2003-02       Impact factor: 0.959

2.  The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease).

Authors:  C Weik; L Greiner
Journal:  Scand J Gastroenterol       Date:  1999-12       Impact factor: 2.423

3.  Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

Authors:  H L Bonkovsky; J M Woolley
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.

Authors:  Julie Ratcliffe; Louise Longworth; Tracey Young; Stirling Bryan; Andrew Burroughs; Martin Buxton
Journal:  Liver Transpl       Date:  2002-03       Impact factor: 5.799

Review 5.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

6.  Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia.

Authors:  S Trippoli; M Vaiani; S Linari; G Longo; M Morfini; A Messori
Journal:  Haematologica       Date:  2001-07       Impact factor: 9.941

7.  Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients.

Authors:  F Arpinelli; G Visonà; R Bruno; G De Carli; G Apolone
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

Review 8.  Gender variations in clinical pain experience.

Authors:  A M Unruh
Journal:  Pain       Date:  1996 May-Jun       Impact factor: 6.961

9.  Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization.

Authors:  H I Andersson; G Ejlertsson; I Leden; C Rosenberg
Journal:  Clin J Pain       Date:  1993-09       Impact factor: 3.442

10.  The natural history of epistaxis in hereditary hemorrhagic telangiectasia.

Authors:  O S AAssar; C M Friedman; R I White
Journal:  Laryngoscope       Date:  1991-09       Impact factor: 3.325

View more
  22 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.

Authors:  Shruti Chaturvedi; Marianne Clancy; Nicole Schaefer; Olalekan Oluwole; Keith R McCrae
Journal:  Thromb Res       Date:  2017-03-09       Impact factor: 3.944

3.  Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.

Authors:  K Young; L T Krebs; E Tweedie; B Conley; M Mancini; H M Arthur; L Liaw; T Gridley; Cph Vary
Journal:  Dev Biol       Date:  2015-10-19       Impact factor: 3.582

4.  The Subjective Experience of Patients Diagnosed with Hereditary Hemorrhagic Telangiectasia: a Qualitative Study.

Authors:  Laura Geerts; Carole Fantini-Hauwel; Elodie Brugallé; Odile Boute; Frédéric Frénois; Lydie Defrance; Sylvie Manouvrier-Hanu; Florence Petit; Pascal Antoine
Journal:  J Genet Couns       Date:  2016-10-28       Impact factor: 2.537

Review 5.  Valuing the "Burden" and Impact of Rare Diseases: A Scoping Review.

Authors:  Julien Delaye; Pasquale Cacciatore; Anna Kole
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

6.  Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.

Authors:  Thi Thao Truc Le; Guillaume Martinent; Sophie Dupuis-Girod; Antoine Parrot; Anne Contis; Sophie Riviere; Thierry Chinet; Vincent Grobost; Olivier Espitia; Brigitte Dussardier-Gilbert; Laurent Alric; Guillaume Armengol; Hélène Maillard; Vanessa Leguy-Seguin; Sylvie Leroy; Murielle Rondeau-Lutz; Christian Lavigne; Shirine Mohamed; Laurent Chaussavoine; Pascal Magro; Julie Seguier; Mallorie Kerjouan; Sylvie Fourdrinoy
Journal:  Orphanet J Rare Dis       Date:  2022-07-19       Impact factor: 4.303

7.  Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.

Authors:  Juan Du; Yan Zhu; Yu-Lin Zhang; Sha Li; Jing Huang; Xiao-Hua Luo; Lin Liu
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

8.  Life experiences of individuals with hereditary hemorrhagic telangiectasia and disclosing outside the family: a qualitative analysis.

Authors:  Leigh Ann Higa; Jamie McDonald; Deborah O Himes; Erin Rothwell
Journal:  J Community Genet       Date:  2015-09-04

9.  Impact of pulmonary arteriovenous malformations on respiratory-related quality of life in patients with hereditary haemorrhagic telangiectasia.

Authors:  Sandra Blivet; Daniel Cobarzan; Alain Beauchet; Mostafa El Hajjam; Pascal Lacombe; Thierry Chinet
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

10.  Left atrial appendage closure for stroke prevention in patients with atrial fibrillation and hereditary hemorrhagic telangiectasia.

Authors:  Sebastiaan Velthuis; Martin J Swaans; Johannes J Mager; Benno J W M Rensing; Lucas V A Boersma; Martijn C Post
Journal:  Case Rep Cardiol       Date:  2012-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.